Skip to main content
American Pain Society
Menu
Login
Search
  • Membership
    • Membership Overview
    • Membership Categories
    • Member Spotlight
      • Spotlight – Salimah Meghani
      • Spotlight – Adam Hirsh
      • Spotlight – Deb Gordon
      • Member Spotlight Archive
      • Spotlight – Arian Nachat, MD FABEM FABHPM
      • Spotlight – Benedict J. Kolber, PhD
      • Spotlight – Beth Darnall, PhD
      • Spotlight – Gonzalo Flores, LAc MAcOM
      • Spotlight – Gregory Terman, MD PhD
      • Spotlight – J. Bruce Hillenberg, PhD ABPP
      • Spotlight – Jeffrey Mogil, PhD
      • Spotlight – Neil Singla, MD
      • Spotlight – S. Stevens Negus, PhD
      • Spotlight – Sean Ustic, PharmD
      • Spotlight – Story Landis, PhD
      • Spotlight – Darnall 2
      • Spotlight – Anna Wilson
      • Spotlight – Seena Ajit
      • Spotlight – Marie Bement
      • Spotlight – Peter Grace
      • Spotlight – David Thomas
    • Member Demographics
    • Recruit
    • Join/Renew
    • Membership Directory
    • January 2019 New Members
    • February 2019 New Members
  • Meetings and Events
    • 2019 Scientific Meeting
      • 2019 Scientific Meeting
        • 2019 Speaker Media Kit
        • Scientific Meeting: Science Landing Page
        • Scientific Meeting: Clinical Landing Page
        • Refer a colleague
        • Social Media Champion
        • 2019 Social Media Champions
        • Registration Rates
        • Hotel and Travel
        • 2019 Meeting Prospects
          • Thank You
        • Schedule
        • Continuing Education
        • 2019 Speaker Highlight
        • 2019 SIG Schedule
        • Accepted Posters
        • Spring Pain
        • Fundamentals Course
        • Conference on Analgesic Trials
        • Early Career Forum
        • Data Blitz
        • Exhibits and Support
        • Sponsorship Opportunities
        • Early Career Forum Mentors
        • 2019 Young Investigator Recipients
        • Scientific Program Committee
        • 2019 App Tips
    • 32nd Annual Scientific Meeting Evaluation
    • 2017 Call for Poster Abstracts
    • Past Meetings
      • Abstract Database
    • Email Landing Page 2017
    • 2018 Scientific Summit Poster Presenters in the Media
  • Education
    • Guidelines
      • Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease
      • Archived Guidelines
    • The Journal of Pain
      • Journal of Pain iPad App
    • Journal Summaries
      • JOP July 2018 – 1
      • JOP July 2018 – 2
      • Clinical JOP July 2018 – 1
      • Clinical JOP July 2018 – 2
      • PAIN July 2018 – 1
      • PAIN July 2018 – 2
      • JOP August 2018 – 1
      • JOP August 2018 – 2
      • Clinical JOP August 2018 – 1
      • Clinical JOP August 2018 – 2
      • PAIN August 2018 – 1
      • PAIN August 2018 – 2
      • JOP September 2018 – 1
      • JOP September 2018 – 2
      • JOP October 2018 – 1
      • JOP October 2018 – 2
      • JOP November 2018 – 1
      • JOP November 2018 – 2
      • JOP December 2018 – 1
      • JOP December 2018 – 2
      • JOP January 2019 – 1
      • JOP January 2019 – 2
      • JOP February 2019 – 1
      • JOP February 2019 – 2
      • JOP March 2019 – 1
      • JOP March 2019 – 2
    • Principles of Analgesic Use
    • APS E-News
      • E-News Archives
      • Member Stories
    • Online Education Programs
    • Training in Pain and Associated Symptoms Research – Nursing
    • The Methadone Safety Guidelines: A Live Webinar
    • 2010 Revised Questionnaire
    • Events Calendar
    • CE Mission Statement
    • Webinars
    • Resources
      • Resource – Fibromyalgia
      • Resources – Sickle Cell Disease
      • Chronic Low Back Pain
    • Clinical Centers Guide
    • Military/Veterans SIG Meeting
    • Psychosocial Research SIG Meeting
    • Primary Care SIG Meeting
    • Pain and Disparities SIG Meeting
    • Ethics/Pain Rehabilitation SIG Meeting
    • Plenary Lecture: The Biology of Infant and Childhood Pain: It All Begins Here
    • Kerr Lecture: Distributed Processing of Pain: From the Spinal Cord to the Brain
    • Fordyce Lecture: Simplifying Evidence-Based Pain Self-Management Therapies for Chronic Pain: Rationale, Efficacy, and Implementation
    • Plenary Lecture: In Pursuir of More Powerful Non-Pharmacologic Treatments for Musculoskeletal Pain with Centralized Features
    • Plenary Lecture: Taking Aim is Easier When You Know the Target: Moving Toward Mechanism-Based Pain Assessment
    • Plenary Lecture: Assessment and Management of Neuropathic Pain: Advances, Challenges, and Opportunities
    • Plenary Lecture: Spinal Mechanisms of Spinal Cord Injury-Induced Neuropathic Pain: Implications for Novel Therapeutic Targets
    • Plenary Lecture: Variability in the Pain Experience after Injury
    • Neurobiological Mechanisms Supporting Integrative and Mind-Body Therapies for Pain
    • Bottom-up vs. Top-down: The Search for Effective Mechanisms in Psychosocial Treatments for Chronic Pain
    • Novel Mechanisms Underlying Risk for Acute and Chronic Post-Surgical Pain: Role of Peripheral Pain Processing, Central Sensitization, and Genomics
    • Psychology Treatments for Chronic Pain: Who Benefits & Why?
    • Descending Modulation of Pain and the Endocannabinoid System: Sites, Mechanisms, and Therapeutic Potential
    • Muscle Pain Mechanisms: It’s Time to Dive Deep
    • Mechanism-Based Approach to Clinical Trial Design in Chemotherapy-Induced Peripheral Neuropathy
    • At the Intersection of Affect Regulation, Reward/Value Process, and Placebo: Altered Human Psychological, Neurobiological, and Opioidergic Systems in Chronic Pain
    • Putting the Spotlight on Social: An Innovative Multidisciplinary, Multi-Species Approach for Examining the Influence of Social Context in Pain
    • Migraine and Sleep Deficiency in Adolescents: Understanding Shared Mechanisms for Bench to Bedside
    • Novel Directions in Basic Science Research: Rita Allen Scholars
    • Exploiting Cellular and Molecular Mechanisms of Neuroinflammation for New Treatments of Chronic Pain
  • Funding Opportunities
    • Grants
      • Where Are Future Leaders Now?
      • Future Leaders
        • 2009-fl-laura-simons
        • Barbara Hastie
        • Robert Edwards
        • Susan Dorsey
        • Beth Darnall
        • Jill Fehrenbacher
        • Ted Price
        • Anna Long
        • Jamie Rhudy
        • Laura Frey Law
        • Lisa Loram
        • Magali Millecamps
        • Edgar Romero-Sandoval
        • Gregory Dussor
        • Khara Ramos
        • Lynnae Schwartz
        • Michelle Fortier
        • Christopher King
        • Jennifer Lee
        • Kimberly Sibille
        • Shivani Ruparel
        • Steve Davidson
        • Claudia Campbell
        • Jennifer DeBerry
        • Tim Doyle
        • Adam T. Hirsh, PhD
        • David A. Seminowicz, PhD
        • Ohannes K. Melemedjian, PhD
        • Burel R. Goodin, PhD
        • 2014 Future Leaders in Pain Research Recipients
        • Future Leaders – Past Recipients
      • Sharon S. Keller Chronic Pain Research Grant
        • Sharon S. Keller Grant Past Recipients
      • Future Leader Spotlight – Copits
      • Future Leader Spotlight – Janevic
      • Future Leader Spotlight – Jarrahi
    • APS and Pfizer IGLC
    • METER Mayday Award
    • Pfizer IGLC for Pain Research
  • Get Involved
    • 2019 Call for Nominations
    • Awards & Grants
      • Clinical Centers of Excellence in Pain Management
        • CCOE Recipients
        • 2009 Clinical Centers of Excellence in Pain Management Award – Special Commendation
          • John C. Liebeskind Early Career Scholar Award
            • David A. Seminowicz, PhD
            • Laura E. Simons, PhD
            • Claudia M. Campbell, PhD
        • 2014 Clinical Centers of Excellence Award Recipients
        • 2013 CCOE Recipients
        • 2012 CCOE Recipients
        • 2012 CCOE Ceremony
        • 2010 CCOE Special Commendations
        • 2011 CCOE Recipients
        • 2010 CCOE Recipients
        • CCOE Applications
        • CCOE Past Recipients
      • Distinguished Service Award
        • Edward Michna, JD MD
        • Charles E. Inturrisi, PhD
        • David A. Williams, PhD
      • Elizabeth Narcessian Award for Outstanding Educational Achievements in the Field of Pain
        • Penney Cowan
        • Joanna Girard Katzman, MD MSPH
        • Charles Argoff, MD
      • Kathleen M. Foley Journalist Award
        • Rita Rubin
        • Michelle Andrews
        • Judy Foreman
      • Jeffrey Lawson Award for Advocacy in Children’s Pain Relief
        • Elliot Krane
        • Carlton Dampier, MD
        • Anna Tadio
      • John and Emma Bonica Public Service Award
        • Ann O’Mara
        • Phillip A. Pizzo, MD
        • Dennis C. Turk, PhD
        • Robert H. Dworkin
      • Rita Allen Foundation Award in Pain
        • Rita Allen Foundation Award Recipients
      • Wilbert E. Fordyce Clinical Investigator Award
        • Jennifer Haythornthwaite, PhD
        • William Maixner
        • Mark P. Jensen, PhD
      • Frederick W.L. Kerr Basic Science Research Award
        • Kathleen Sluka, PT PhD
        • Jeffrey S. Mogul, PhD
        • Michael J. Iadarola, PhD
      • 2015 CCOE Recipients
      • 2015 Distinguished Service Award – Savage
      • 2015 Foley Award – Thernstrom
      • 2015 Bonica Service Award – Rappaport
      • 2015 Fordyce Award – Clauw
      • 2015 Kerr Basic Science Award – Woolf
      • 2015 Jeffrey Lawson Award – Johnston
      • 2015 Liebeskind Award – Hirsh
      • 2015 Narcessian Award – Fishman
      • 2016 Award Nominations
      • 2016 Narcessian Award – Friedrichsdorf
      • 2016 Lawson Award – Chambers
      • 2016 Liebeskind – Trost
      • 2016 Bonica Award – Christo
      • 2016 CCOE Award Recipients
      • 2016 Fordyce Award – Mackey
      • 2016 Kerr Award – Gold
      • 2016 Foley Award – Peachman
      • Brewer Distinguished Teaching of Psychology Award
      • 2017 Distinguished Service Award – Fillingim
      • 2017 Narcessian Award – Kitlinski
      • 2017 Kerr Award – Gereau
      • 2017 Lawson Award – von Baeyer
      • 2017 Bonica Award – Porter
      • 2017 Liebeskind Award – Goodin
      • 2017 Fordyce Award – Kerns
      • 2018 Distinguished Service – Herndon
      • 2018 Narcessian – Gallagher
      • 2018 Kerr – Coghill
      • 2018 Lawson – Grunau
      • 2018 Bonica – Moseley
      • 2018 Liebeskind – Merlin
      • 2018 Fordyce Award – BThorn
      • 2018 Kerr Award – RCoghill
      • 2018 Bonica Award – LMoseley
      • 2018 Lawson Award – RGrunau
      • 2018 Liebeskind Award – JMerlin
      • 2018 Narcessian Award – RGallagher
      • 2019 Liebeskind Award – Noel
      • 2019 Bonica Award – Thomas
      • 2019 Kerr Award – Pasternak
      • 2019 Distinguished Award – Walco
      • 2019 Narcessian Award – Mogil
      • 2019 Fordyce Award – Tait
      • 2019 Lawson Award – Riddell
    • Special Interest Groups
      • Advancing the Science of Quality
      • Clinical Trials
        • APS-CAT Webinar
      • Ethics
      • Genetics and Pain
      • Geriatric Pain
      • Measurement of Pain and Its Impact
      • Nursing
      • Pain Education
      • Pain in Sickle Cell Disease
      • Pain Rehabilitation
      • Palliative Care
      • Primary Care
      • Psychosocial Research
      • Basic Science
      • Pain and Disparities
      • Pharmacotherapy
      • Pain in Infants, Children, and Adolescents
      • Complementary and Alternative Medicine
      • Military/Veterans SIG
      • Basic Science SIG – Election
      • Headache SIG
      • Sex & Gender in Pain and Analgesia
      • SIG Election – Psychosocial
      • SIG Election – Basic Science
      • SIG Election – Pediatric
    • Regional Societies
      • Southern Pain Society
        • Organization and Membership
        • Officers and Board Members
      • Midwest Pain Society
        • Board and Officers
        • MPS Mission Statement
        • Meeting Workshop Handouts
      • Eastern Pain Association
        • Why Join?
        • EPA Mission Statement
      • Western Pain Society
      • Greater Philadelphia Pain Society
    • Commercial Support
    • Advocacy
      • Pain Care Coalition
      • Pain Care Coalition Timeline
      • 2016 National Pain Strategy Presentation
      • July 2018 Advocacy FDA
      • July 2018 Advocacy NIH
      • July 2018 Advocacy NIH HEAL
    • Pain Research Fund
      • PRF Donors
      • PRF FAQ
    • 2016 Distinguished Service Award – Haythornthwaite
    • Early Career Resources
      • Early Career Advisory Group Members
      • Early Career Job Board
      • Training and Career Development Applicant Resources
    • ECAG Application
    • ECAG Vice Chair Nomination
    • Call for Volunteers
    • ECAG Poster Tips
      • Who’s Who in APS
        • Board of Directors
        • Committee and Special Interest Group Chairs
        • APS Staff
        • Organizational Structure
        • Strategic Plan
        • APS Bylaws
        • History of APS
        • Position Statements
          • Statement on Research, Funding, and Opioids
          • Society Blog View
        • Code of Ethics
        • Conflict of Interest Policy
          • Financial Conflict of Interest Policy
        • Pain Research Agenda
        • IASP
        • Newsroom
          • American Pain Society’s Annual Scientific Meeting Convenes in New Orleans, May 8-11
          • Adolescent Chronic Pain Costs $19.5 Billion a Year in the United States
          • New Method Helps Doctors Check Pain Drug Compliance
          • New Study Assesses Benefits of Cognitive Pain Relief Methods
          • Pain Intensity Can Predict Head and Neck Cancer Survival
          • Study Estimates Persistent Pain Incidence at 19% of U.S. Adults
          • Study Examines How Doctors Use Prescription Drug Monitoring Programs
          • Low-Dose Vaporized Cannabis Improves Neuropathic Pain
          • American Pain Society Releases Pain Research Agenda for the 21st Century
          • About Newsroom
          • American Pain Society and Journal of Family Practice To Co-sponsor Pain Care Conference for Primary Care Physicians
          • American Pain Society Announces $150,000 Pain Research Grant Program
          • American Pain Society Establishes Private Pain Research Fund
          • American Pain Society Executive Selected as Mayday Fellow
          • American Pain Society Hosting Two Symposia at PAINWeek
          • American Pain Society Presents 2012 Achievement Awards
          • American Pain Society Presents 2013 Achievement Awards
          • American Pain Society Presents 2014 Achievement Award
          • American Pain Society Publishes New Clinical Practice Guideline on Methadone Safety
          • American Pain Society To Provide Grant Support for Pain Research Forum’s “Papers of the Week”
          • Anxiety and Pain Fear Before Surgery Predict Chronic Post-surgical Pain
          • Archived News Releases
          • Cannabinoid Shown Effective as Adjuvant Analgesic for Cancer Pain
          • Drug Treatments for Heroin Addiction Heighten Pain Sensitivity
          • Genetic Alteration Predicts Pain Recovery After Sexual Assault
          • Health Care Reforms Will Change How Pain Is Assessed and Treated
          • High-dose Opioid Treatment Associated with Mental Health and Medical Comorbidities
          • Inadequate Pain Research Funding Hampers Effort to Find Safer and More Effective Treatments
          • Injury Fears Can Predict Impairment in Low Back Pain Patients
          • Internalized Stigma Linked with Poor Self Esteem and Pain Self-Efficacy
          • Motives Assessed for Opioid Misuse Among Adolescents
          • Negative Physician Attitudes About Opioid Pain Meds Linked with Lower Prescribing
          • New SmartPhone Apps Help Doctors Manage Pain Patients
          • No Relief Yet for Brutal Oral Cancer Pain, but Cannabinoids May Offer Some Hope
          • One-fourth of Breast Cancer Surgery Patients Have Persistent Pain
          • Pain Research Funding Inadequate in the Face of Soaring Incidence and Treatment Costs
          • Pain Research Yielding Encouraging Discoveries, But Funding Cuts Threaten Future Advances
          • Positive Activities Administered Online Help in Pain Management
          • Primary Care Doctors Prefer NSAIDS for Chronic Pain Treatment
          • REMS Statement
          • Risk Factor Management Helps Prevent Migraine Attacks
          • Sedatives and Alcohol Increase Risk for Pain Medication Adverse Events
          • Study Shows Pain Drug Craving Occurs With or Without Risk for Misuse
          • Severe Pain in Sexual Assault Survivors Often Not Treated
          • Severity of Acute Low Back Pain Predicts Development of Chronic Pain
          • Spinal Manipulative Therapy Lessens Central Pain Sensitization
          • Study Assesses Differences in Physician and Patient Pain Assessments
          • Study Assesses Mood Disorders with TMJ Pain
          • Study Assesses Pain and Quality of Life in Ugandan HIV Patients
          • Study Assesses Role of Caregiver Anxiety on Children’s Pain
          • Study Examines Treatment Responses in TMD Patients
          • Study Explores Role of Impaired Sleep in Fibromyalgia Pain
          • Study Evaluates Frequency of Pediatric Pain Assessments
          • Study Links Pre-operative Breast Cancer Pain to Inflammatory Mechanisms
          • Study Shows Pain Coping Success with Acceptance and Commitment Therapy
          • Study shows Physiological Markers for Neonate Pain
          • Study Shows Predictors of Functional Change in Older Women with Recurrent Pain
          • The American Pain Society Presents Full-Day Program at PAINWeek 2012
          • Training the Brain Could Help Reduce Pain
          • University of Florida Psychologist Roger Fillingim, PhD, Becomes President of the American Pain Society
          • University of Washington Anesthesiologist Gregory W. Terman, MD PhD Becomes President of the American Pain Society
          • Yoga Shown Effective for Treating Chronic Neck Pain
          • Study Shows Links of Childhood Pain to Adult Chronic Pain and Fibromyalgia
          • Newsroom Press Releases
            • APS Endorses NPS
            • Study Shows Tai Chi Can Help Relieve Chronic Neck Pain
            • Post-surgical Pain Management Can Influence Progression to Chronic Pain
            • American Pain Society Presents 2017 Achievement Awards
            • American Pain Society Encouraged by Pain Research Funding Progress
            • American Pain Society Scientific Meeting, April 3-6, Milwaukee
            • langevin-plenary
            • moron-concepcion-plenary
            • koroshetz-plenary
          • Newsroom 2013 News Releases
          • Newsroom 2014 News Releases
          • Press Room – Pain Education in Physical Therapy Schools
          • Press Room – Misuse of Therapeutic Opioids
          • Press Room – Meditation Can Reduce Chronic Neck Pain
          • Press Room – Link of Preexisting Mental Disorders
          • APS Scientific Meeting in Palm Springs
          • Nerve Involvement Explains Why Some Cancers are Very Painful
          • American Pain Society Presents 2014 Achievement Awards
          • American Pain Society Honors Clinical Centers of Excellence in Pain Management Award Recipients
          • Strong Evidence Still Lacking on Medical Marijuana for Pain
          • Fibromyalgia Has Central Nervous System Origins
          • Yoga and Chronic Pain Have Opposite Effects on Brain Gray Matter
          • Newsroom 2015 Releases
          • Patient-Centered Outcomes Studies Needed in Pain Management
          • Improving Sleep Quality Has Pain Control Benefits
          • Use of Multiple Pharmacies Can Predict Opioid Overdosing
          • Inhaled Cannabis Shown Effective for Diabetic Neuropathy Pain
          • NIH Study Shows Prevalence of Chronic or Severe Pain in U.S. Adults
          • Physical Therapy for Carpal Tunnel Syndrome Pain Often As Effective as Surgery
          • Mental Disorders Increase Risk for Eventual Chronic Pain in Adolescents
          • Study Assesses Long-term Impact of Post-surgical Pain in Children
          • Newsroom 2016 News Releases
            • American Pain Society Publishes Clinical Practice Guideline for Post-surgical Pain Management
          • Study Assesses Impact of Opioid Risk Reduction Initiatives
          • American Pain Society Annual Scientific Meeting, Austin, May 11-14
          • Message CDC Guidelines
          • APS and Pfizer Grant Fund
          • Better Self Management Improves Outcomes for Chronic Pain Care
          • Politics of Pain Epitomizes U.S. Liberal-Conservative Divide
          • Psychological Flexibility Might Be the Key to Better Cognitive-Behavioral Interventions
          • APS Presents 2016 Achievement Awards
          • APS Honors Clinical Centers of Excellence in Pain Management Award Recipients
          • Evidence Shows Benefits of Psychological Care in Pain Management
          • American Pain Society Awarded Research Grant from Mayday Fund
          • American Pain Society Offers Guidance on Medical Marijuana for Pain
          • Study Shows Pain Often Improves in Older Veterans
          • Study showsDistress Intolerance Associated with Opioid Misuse
          • Brain Stimulation Technique Shown Effective in Phantom Limb Pain
          • Early Childhood Pain Can Predict Chronic Pain in Adolescence
          • American Pain Society Urges Congress to Oppose Steep Budget Cuts for National Institutes of Health
          • Newsroom 2017 News Releases
          • Holistic, Patient Centered Care Gaining Acceptance for Pain Management
          • Wearable Devices Communicate Vital Brain Activity Information
          • Practical Clinical Trials Can Help Find Alternatives to Opioids
          • Better Self-Management Improving VA Outcomes for Chronic Pain Care
          • Study Links Sleep Patterns with Pain Persistence After Pediatric Surgery
          • Study Shows Cognitive Behavioral Therapy Improves Functioning for People with Chronic Pain
          • American Pain Society’s 2018 Annual Meeting Features New, Single-theme Format
          • Pain Severity Leading Predictor of Prolonged Opioid Use After Surgery
          • American Pain Society Supports Passage of Marijuana Effective Studies Act
          • American Pain Society Selects Future Leaders in Pain Research Grant Recipients
          • Study Shows High Rate of Chronic Pain in Homeless Older Adults
          • Study Explores Patient-Doctor Communication About Opioid Tapering
          • American Pain Society Scientific Summit Explores Pain Mechanisms
          • American Pain Society’s 2018 Annual Meeting Explores Pain Mechanisms
          • Sleep Improves Pain and Post Traumatic Stress Disorder Symptoms in Youth
          • Effective Pain Assessments Achieved by Targeting Multiple Pain Mechanisms
          • Post-surgery Pain Resolution Mechanisms Can Explain Healing Variability
          • Babies Feel Pain Even if They’re Not Crying
          • Literacy Deficiencies Restrict Access to Cognitive-Behavioral Pain Therapy
          • American Pain Society Endorses NIH Initiative to Curb Opioid Addiction
          • William Maixner, DDS, PhD Elected American Pain Society President
          • American Pain Society Endorses Compromise Marijuana Studies Act
          • Improved Access to Alternative Care Is Best Option to Curb Opioid Misuse
          • Newsroom 2018 News Releases
          • Pain Rehab Programs without Opioids Proving Effective
          • American Pain Society Selects Tonya Palermo, PhD Treasurer and Three New Directors
          • Online Acceptance and Commitment Therapy Effective for Fibromyalgia
          • Newsroom 2019 News Releases
        • Privacy Policy
        • Contact Us
        • Annual Reports
        • Career Center
        • 2016 Bylaws Proposed Changes
        • Call for Volunteers
        • APS News
          • General Blog View
            • APS Guidelines Set High Standard of Excellence
            • Funding Announcement
            • Member Benefit: The Power of Collaboration
            • Pain Research Agenda for the 21st Century
            • Register Now
            • 2015 Keller Grant Recipients
            • Clinical Trial Studies Effectiveness of Jyoti Meditation
            • Chiropractic Physicians Urge Conservative Approach to Pain Management
            • Closing the Sex Gap in Preclinical Pain Research
          • 2019 Plenary Biographies
            • Health & Wellness
  • Pain Care Outcomes Unaffected by Opioid Dose Reductions
    • Board – Resources
    • Board – Meetings
    • Board – Reporting
      • Board – Minutes
  • Health News

Sucralose and Immunotherapy: Surprising Findings You Should Know!

Sucralose and immunotherapy

Introduction

Immunotherapy is the most important treatment for cancer-like catastrophes. Sucralose is the artificial sweetener used as an alternative to natural or refined sugar. Sucralose is the common ingredient in low-calorie delicacies, diet drinks, and supplements. Experts are exploring the effects of such sucralose on cancer treatments. Some research raises concerns about the connection between Sucralose and Immunotherapy effectiveness. This blog will provide a complete detail on how this sugar substitute can hinder the response of the immune system in cancer patients.

What is sucralose?

Sucralose is a substitute for sugar that contains zero calories, unlike sugar. It is 600 times sweeter than sugar and has a higher glycemic index. There are a variety of brands that sell sucralose in the market. It is commonly used in:
  • Low-calorie snacks
  • Diet drinks
  • Chewing gums
  • Sugar-free desserts
  • Protein supplements
The use of artificial sweeteners is FDA-approved, but there are studies that show the probability of immune modulation during cancer treatments.

Understanding Immunotherapy:

Immunotherapy is a common treatment for cancer patients that helps enable the immune system to detect and destroy cancer cells. Some common forms are:
  • Monoclonal antibodies
  • Checkpoint inhibitors
  • Cytokine therapy
  • CAR T-cell therapy
All of these treatments are meant to work on immune cells, especially on active T-cells. A poor immune system can have a huge impact on cancer therapies, so it is essential to take preventive measures that affect immunity.

Sucralose and Immune System Response:

While immune therapy boosts immunity, some studies claim that sucralose reduces the immune function. The sugar substitute affects the activation of T-cells, which hinders immunotherapy used in cancer treatments. In 2023, a study published in Nature found that mice fed with higher levels of sucralose ultimately experienced lower response to T-cells. With reduced T-cells, the immune defense against tumors is also reduced in mice. Key concerns:
  • Lowered production of T-cells
  • Decreased immune defense system
  • Reduced immune checkpoint response
These concerns can be a nightmare for immunotherapy, as they can affect the process of detection and elimination of cancer cells.

Sucralose and Immune Modulation

The changes in immune responses are known as immune modulation. In some conditions, it appears that sucralose can suppress the immune system. It may hinder gene expression in immune cells, causing harm to their effectiveness.

Studies claim that sucralose affects:

  • Metabolism and response of immune cells
  • Gene expression related to immune tolerance and inflammation
  • Cytokine signaling, reducing immune communication
Such factors can weaken the immune system, followed by a bad impact on the cancer treatments.

Sucralose immunotherapy research

According to the studies mentioned above, sucralose affects the immune checkpoint inhibitors. An immune checkpoint inhibitor is a form of immunotherapy that works by activating T-cells for rigorous destruction of cancer cells. Research findings:
  • Mice with cancer were given sucralose, which caused reduced activation of T-cells.
  • The mice also reacted oppositely to the checkpoint inhibitor therapy.
  • Excessive sucralose reduced the ability of the immune system to fight cancer cells.

Sucralose impact on immune Cells:

Apart from reducing the immune sensitivity, sucralose also affects the immune cells that eliminate tumor cells. Some of the immune cells are:
  • Helper T-cells – coordinate attacks on immunity
  • CD8+ T-cells – cells that target the tumor
  • Dendritic cells – essential for antigen presentation
Poor immune cell coordination leads to decreased ability to tackle cancer, followed by less effective immunotherapy.

Sucralose side effects during immunotherapy

There is no such claim of any issue with consuming sucralose occasionally. But cancer patients undergoing immunotherapy may have higher chances of encountering side effects due to sucralose intake. Potential concerns:
  • Affects the treatment of cancer
  • Poor immune response
  • Impacts immune signaling by affecting gut microbes
  • Inflammatory imbalances that harm immune control
A mild change in the diet can affect the connection between Sucralose and Immunotherapy, making it difficult to treat cancer.

Sucralose and cancer treatment effectiveness

As per the research, sucralose can disrupt the gut flora and cytokine signaling. Eventually, it is stated that artificial sweeteners can decrease the activation of T-cells, causing difficulty in cancer treatments. It can even alter the expression of a gene in an immune cell that disrupts immunotherapy. Hence, it states that the cancer therapies can massively fail due to the sucralose consumption. Sucralose and immunotherapy

Should you avoid sucralose during immunotherapy?

Cancer patients can have sucralose in moderate amounts, as there is no official ban on sucralose yet. But experts suggest consuming in moderation, especially if the person is on immunotherapy. Recommendations:
  • Adapt alternatives like monk-fruit, raw honey, or stevia in moderation
  • Consume limited diet food or drinks containing sucralose
  • Better to have a recommendation from an immunologist or oncologist

Healthier sweetener alternatives:

To avoid the harmful effects of sucralose on immunotherapy, consider:
  • Erythritol – does not affect the immune system
  • Stevia – it is a natural sweetener that does not disrupt immunotherapy
  • Monk fruit – promotes gut health and is high in antioxidants
These substitutes are highly recommended as they do not cause any concern about sucralose on immune modulation.

Final thoughts:

Immunotherapy is the cornerstone of cancer treatment, so it is necessary to consider that no diet or lifestyle affects its process. As research claims the impact of sucralose on the immune system, it is better to check the connection between Sucralose and Immunotherapy. Studies claim sucralose alters T-cell activation and immune signaling, causing failure of immunotherapy and cancer treatment. While more evidences are required, it is better to limit the sucralose consumption, especially if you are under immunotherapy. It is essential to have a healthy diet and consult a health expert before changing your food choices during cancer treatments.

Frequently Asked Questions (FAQs)

  1. Can Sucralose and Immunotherapy be ineffective altogether?
  2. Yes, sucralose reduces the effectiveness of the immunotherapy by targeting active T-cells and suppresses its effectiveness. It causes difficulty in cancer treatments by reducing the ability to destroy tumor cells.
  3. Does sucralose affect immune response?
  4. Sucralose may cause immune signaling and immune modulation, disrupting cell activation, followed by a poor immune system.
  5. Can a cancer patient have sucralose during immunotherapy?
  6. To obtain a better response from immunotherapy, it is advised to consume sucralose in moderate quantities.
  7. How does sucralose affect immune cells?
  8. It impacts cytokine signaling and active cells, which are essential to eliminate tumor cells through immunotherapy.
  9. Are there any alternatives to sucralose for patients under immunotherapy?
  10. Monk fruit, stevia, and erythritol are safer substitutes to artificial sweeteners that do not harm immune cells and their performance.
American Pain Society
  • 8735 W. Higgins Road, Suite 300, Chicago, IL 60631
  • 847.375.4715
  • info@americanpainsociety.org
  • Facebook
  • Twitter
  • Calendar
Career Center ›
Newsroom ›
About Us ›

©2019 American Pain Society • Privacy Policy »